Larvol Delta - AXALAP-Phase-Ib-Study-of-Axatilimab-in-Combination-With-Olaparib-in-BRCA12-and-PALB2-Associated-Metastatic-HER2negative-Breast-Cancer

Lynparza (olaparib) - Merck (MSD), AstraZeneca

Niktimvo (axatilimab-csfr) - Syndax Pharma, Incyte

http://clinicaltrials.gov/ct2/show/NCT06488378

Sep 3, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next